Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

ClinicalTrials.gov ID: NCT00859898

Public ClinicalTrials.gov record NCT00859898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 11:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin 10 mg in Combination With Metformin as Initial Therapy as Compared With Dapagliflozin 10 mg Monotherapy and Metformin Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to compare the change from baseline in hemoglobin A1C achieved with dapagliflozin 10 mg in combination with metformin XR as compared with metformin XR monotherapy and compared with Dapagliflozin monotherapy, after 24 weeks of oral administration of double-blind treatment. The safety of treatment with dapagliflozin will also be assessed in this study

Study identification

NCT ID
NCT00859898
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,093 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 77 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2009 (Type not available)
Primary completion
May 2010 (Actual)
Completion
May 2010 (Actual)
Last update posted
Jul 7, 2016

2009 – 2010

United States locations

U.S. sites
64
U.S. states
24
U.S. cities
56
Facility City State ZIP Site status
International Institute Of Clinical Research Ozark Alabama 36360 —
Clinical Research Advantage, Inc./Mesa Family Med Ctr, Pc Tempe Arizona 85282 —
Clinical Research Advantage, Inc. Tempe Arizona 85282 —
John Muir Physician Network Clinical Research Center Concord California 94520 —
Encompass Clinical Research-North Coast Encinitas California 92024 —
Southland Clinical Research Center, Inc. Fountain Valley California 92708 —
Valley Research Fresno California 93720 —
Del Rosario Medical Clinic, Inc. Huntington Park California 90255 —
Irvine Center For Clinical Research, Inc. Irvine California 92618 —
Pacific Sleep Medicine Services (Avastra Clinical Trials) Redlands California 92373 —
Orange County Research Center Tustin California 92780 —
Lynn Institute Of The Rockies Colorado Springs Colorado 80907 —
Radiant Research, Inc. Denver Colorado 80239 —
Clinical Therapeutics Corporation Coral Gables Florida 33134 —
Nextphase Clinical Trials, Inc. Miami Florida 33145 —
Baptist Diabetes Associates Miami Florida 33156 —
Metabolic Research Institute, Inc. West Palm Beach Florida 33401 —
Lake Hartwell Family Medicine Hartwell Georgia 30643 —
Middle Georgia Drug Study Center, Llc Perry Georgia 31069 —
Northwest Clinical Trials Boise Idaho 83704 —
Provident Clinical Research Addison Illinois 60101 —
Cedar Crosse Research Center Chicago Illinois 60607 —
Deerbrook Medical Associates Vernon Hills Illinois 60061 —
Physicians Research Group Indianapolis Indiana 46250 —
Borgess Research Institute Kalamazoo Michigan 49048 —
Olive Branch Family Medical Center Olive Branch Mississippi 38654 —
Clinilabs, Inc. New York New York 10019 —
Metrolina Medical Research Charlotte North Carolina 28209 —
Pharmquest Greensboro North Carolina 27408 —
Crescent Medical Research Salisbury North Carolina 28144 —
Community Health Care, Inc. Canal Fulton Ohio 44614 —
Holzer Clinic, Inc Gallipolis Ohio 45631 —
Wells Institute For Health Awareness Kettering Ohio 45429 —
Newark Physician Associates Newark Ohio 43055 —
Daniel G. Williams, Md Perrysburg Ohio 43551 —
Physician Research, Inc. Zanesville Ohio 43701 —
Gilbert Medical Research, Llc Bethany Oklahoma 73008 —
Tulsa Clinical Research, Llc Tulsa Oklahoma 74104 —
Integris Family Care Yukon Yukon Oklahoma 73099 —
Williamette Valley Clinical Studies Eugene Oregon 97404 —
Dingmans Medical Dingmans Ferry Pennsylvania 18328 —
Integrated Medical Group Pc/Fleetwood Clinical Research Fleetwood Pennsylvania 19522 —
Wellmon Family Practice Shippensburg Pennsylvania 17257 —
Safe Harbor Clinical Research East Providence Rhode Island 02914 —
Southeastern Research Associates, Inc. Greenville South Carolina 29605 —
Holston Medical Group Bristol Tennessee 37620 —
Parkway Medical Group Fayetteville Tennessee 37334 —
Holston Medical Group Kingsport Tennessee 37660 —
Southwind Medical Specialists Memphis Tennessee 38125 —
Dallas Diabetes & Endocrine Center Dallas Texas 75230 —
Endocrine Associates Houston Texas 77004 —
Village Family Practice Houston Texas 77024 —
Juno Research, Llc. Houston Texas 77036 —
Non-Invasive Cardiovascular, Pa Houston Texas 77074 —
Excel Clinical Research Houston Texas 77081 —
Texas Center For Drug Development Houston Texas 77081 —
Midland Clinical Research Center Midland Texas 79707 —
Hill Country Medical Associates New Braunfels Texas 78130 —
Covenant Clinical Research, Pa San Antonio Texas 78229 —
S.A.M. Clinical Research Center San Antonio Texas 78229 —
Avastra Clinical Trials Midvale Utah 84047 —
Seven Corners Medical Center Falls Church Virginia 22044 —
Tidewater Integrated Medical Research Virginia Beach Virginia 23454 —
Northwest Clinical Research Center Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00859898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2016 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00859898 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →